Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
Nielsen VG, George SJ
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of CORM-2 exposure and incubating platelet poor plasma at temperatures below 37 degrees C on coagulation and fibrinolysis. Sodium citrate was used as an anticoagulant.
Summary of Findings
Exposure of plasma to hypothermic temperatures resulted in prolonged onset and slower velocity of clot growth, however, clot strength was unaffected. The onset of fibrinolysis was not delayed at hypothermic temperatures, but the rate of lysis was significantly decreased. CORM-2 exposure increased velocity of clot growth and strength, delayed the onset of fibrinolysis, and slowed the rate of lysis.
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
NormalPlatforms
MorphologyHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components DMSO addedDMSO and CORM-2 addedHematology/ auto analyzer Specific Incubation temperature 27 degrees C29 degrees C31 degrees C33 degrees C35 degrees C37 degrees C